© 2020 – 2023 AEA3 WEB | AEAƎ United Kingdom News
AEA3 WEB | AEAƎ United Kingdom News
News

FDA approves breakthrough Alzheimer’s drug Lecanemab

Drug works with the body’s immune system to clear amyloid protein buildup from the brain

The US Food and Drug Administration (FDA) has approved Lecanemab, a breakthrough drug to treat Alzheimer’s, that is manufactured by biotechnology companies Biogen and Eisai.

The drug is an intravenously administered humanized monoclonal antibody that targets amyloid, the toxic protein in the brain linked to the cognitive disease.

Continue reading…

Related posts

Indonesia plane crash: wreckage pulled from water after aircraft signal detected

AEA3

Boris Johnson raised human rights issues at Orbán meeting, says No 10

AEA3

Queen’s speech: Tories keeping many manifesto pledges, but struggling to fulfil key ones, says thinktank – politics live

AEA3

Pin It on Pinterest

Share This